
TSE:L
This summary was created by AI, based on 10 opinions in the last 12 months.
Loblaw Companies Ltd is recognized as a dominant player in the Canadian grocery and pharmacy sector, benefiting from strong brand loyalty and private label offerings. Despite its robust performance, experts express concerns regarding its valuation, with some calling for caution due to the perception of shrinking growth potential and increased competition from retailers like Walmart and Costco. While some analysts view Loblaw as a defensive investment that could provide stability in uncertain economic times, others critique its recent price surges and suggest trimming positions. The company's acquisition of Shoppers Drug Mart is praised for unlocking profitability, though comparisons with ATD highlight some hesitancy among investors. Overall, while Loblaw has shown resilience amid food inflation, market sentiment varies, indicating mixed outlooks on its future performance.
Competition is fierce from Walmart, Costco, Amazon. Has come up since it's in consumer staples. Low beta, decent dividend, but not a lot of growth ahead of it. He'd look at Dollarama or Couche-Tarde instead. Also, Ontario minimum wage increase has been a detriment.
Their on-line offering will not be threatened by AMZN-Q's grocery delivery.